US authorizes third dose of Pfizer for seniors and high-risk people
The authorization is given for those over 65 years of age, people at high risk of suffering from the disease and those who are in environments with high exposure to the virus.
United States on Wednesday authorized the use of third doses of vaccine covid-19 to Pfizer for over 65 years, people with high risk for the disease and those found in high - exposure to the virus.
"Today's action demonstrates that the science and data currently available continue to guide the FDA's decision-making for covid-19 vaccines during this pandemic," said Janet Woodcock, acting chief of the Food and Drug Administration.
